Expert opinion on therapeutic targets
The IL-33 receptor ST2 as a therapeutic target for hemophilic arthropathy.
Alexander G Lawrence, James S O'Donnell, Peter L Turecek, Padraic G Fallon
Published: 202610.1080/14728222.2026.2619746
No abstract available for this study.